Media relations

HOME>Company>Media relations

title_eng

p1

Prof. Seongho Park at University of Ulsan College of Medicine to Receive 2015 KSR-Taejoon Radiologic

 

%81.jpg

 

 

Prof. Nariya Jo at Seoul National University College of Medicine to receive KSR-Accuzen Promising Young Doctor Award

At 71th 2015 KCR symposium held at Coex, Seoul from Sept. 9th to 12th, the Korean Society of Radiology (President Seunghyeop Kim) and Taejoon Pharm. (President Taeyoung Lee) selected Prof. Seongho Park at University of Ulsan College of Medicine and Prof. Nariya Jo at Seoul National University College of Medicine to be given 14th KSR-Taejoon Radiological Award to and 6th KSR-Accuzen Promising Young Doctor Award, respectively.

At the awards ceremony held on Sept. 11th, Taejoon Pharm. gave as prize money 20 million won to Prof. Seongho Park who won KSR-Taejoon Radiological Award and 5 million won to Prof. Nariya Jo for winning KSR-Accuzen Promising Young Doctor Award.

First created back in 2002 to contribute to the development of radiology by presenting academic visions and increasing research competitiveness in the field of radiology, KSR-Taejoon Radiological Award has been annually given to the contributor who has made the greatest international academic achievement of the year in the field of radiology and so far, there are 14 awardees. First created in 2010 for the purpose of supporting research conducted by young radiologists, this year marks the 6th KSR-Accuzen Promising Young Doctor Award. These two awards are becoming by far the most highly regarded awards in the field of radiology in Korea.

Taejoon Pharm., which successfully renewed its status as an innovative pharmaceutical company certified by the Ministry of Health and Welfare, it manufactured nonionic contrast media and MRI contrast media in 1995 for the first time in Korea and is considered to have the longest history and to be unrivaled in the field. The company produces all the lines of its aseptic finished products using EU GMP-certified facilities. In addition, Taejoon Pharm. is playing a leading role in the field of contrast media by supplying CT, MRI, X-ray contract agents through Accuzen, a company specializing in contrast media.

PrevTaejoon Pharm. to Sponsor 2015 “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Servi
NextTaejoon Pharm.’s Xalost, a Glaucoma Medication, to Enter Chinese Market
List